Free Trial
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

Microbix Biosystems logo
C$0.45 +0.03 (+5.88%)
As of 04/2/2025 03:59 PM Eastern

About Microbix Biosystems Stock (TSE:MBX)

Key Stats

Today's Range
C$0.42
C$0.45
50-Day Range
C$0.37
C$0.55
52-Week Range
C$0.29
C$0.55
Volume
90,873 shs
Average Volume
194,492 shs
Market Capitalization
C$59.27 million
P/E Ratio
17.14
Dividend Yield
2.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Remove Ads
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

Microbix Biosystems' stock was trading at C$0.41 at the start of the year. Since then, MBX shares have increased by 9.8% and is now trading at C$0.45.
View the best growth stocks for 2025 here
.

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:MBX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
17.14
Forward P/E Ratio
22.50
P/E Growth
N/A
Net Income
C$3.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$24.42 million
Cash Flow
C$0.11 per share
Price / Cash Flow
4.13
Book Value
C$0.21 per share
Price / Book
2.18

Miscellaneous

Free Float
N/A
Market Cap
C$59.27 million
Optionable
Not Optionable
Beta
0.34
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (TSE:MBX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners